Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep 8;254(2):178-216.
doi: 10.1016/j.canlet.2007.02.002. Epub 2007 Mar 23.

Oncolytic viruses in cancer therapy

Markus J V Vähä-Koskela  1 , Jari E Heikkilä, Ari E Hinkkanen
Affiliations
Review

Oncolytic viruses in cancer therapy

Markus J V Vähä-Koskela et al. Cancer Lett. .

Abstract

Oncolytic virotherapy is a promising form of gene therapy for cancer, employing nature's own agents to find and destroy malignant cells. The purpose of this review is to provide an introduction to this very topical field of research and to point out some of the current observations, insights and ideas circulating in the literature. We have strived to acknowledge as many different oncolytic viruses as possible to give a broader picture of targeting cancer using viruses. Some of the newest additions to the panel of oncolytic viruses include the avian adenovirus, foamy virus, myxoma virus, yaba-like disease virus, echovirus type 1, bovine herpesvirus 4, Saimiri virus, feline panleukopenia virus, Sendai virus and the non-human coronaviruses. Although promising, virotherapy still faces many obstacles that need to be addressed, including the emergence of virus-resistant tumor cells.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Impediments to virotherapy. This schematic drawing represents a tumor mass, and highlighted are some of the known and putative problems oncolytic viruses are facing. Oncolysis is ongoing in the nodule to the left, whereas tumor destruction is almost complete in the nodules to the right. At the top, a new nodule has formed consisting of virus-resistant cells emerging under the selective pressure of oncolysis. Tumor cells may also avoid viral destruction by hiding within strands of connective tissue.
Fig. 2
Fig. 2
Two hypothetical outcomes of virotherapy. In the upper panel, due to the highlighted problems the therapy will ultimately fail using virus infection alone. Several strategies have therefore been proposed to enhance treatment efficacy in order to achieve complete eradication of the cancer (lower panel). Finding a combination resulting in optimal treatment regimen will probably become increasingly important in the future.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sinkovics J., Horvath J. New developments in the virus therapy of cancer: a historical review. Intervirology. 1993;36:193–214. - PubMed
    1. Sinkovics J.G., Horvath J.C. Newcastle disease virus (NDV): brief history of its oncolytic strains. J. Clin. Virol. 2000;16:1–15. - PubMed
    1. Southam C.M., Moore A.E. Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus. Cancer. 1952;5:1025–1034. - PubMed
    1. Pack G.T. Note on the experimental use of rabies vaccine for melanomatosis. AMA Arch. Derm. Syphilol. 1950;62:694–695. - PubMed
    1. Southam C.M., Hilleman M.R., Werner J.H. Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. J. Lab. Clin. Med. 1956;47:573–582. - PubMed